Colony Bankcorp (CBAN) reported improved operating performance in Q4 2025, with executives detailing on-track integration of TC Federal and momentum in fee-based businesses. The bank targets a 1.20% return on assets for 2026 and signals appetite for further acquisitions.
Gold prices have shattered records, breaching $5,000 per ounce as geopolitical tensions and shifting monetary policies drive a historic rally. Analysts debate whether this is a peak or a new foundation for the safe-haven asset.
The U.S. dollar extended its weekly decline as fresh geopolitical risks, including new tariff threats over Cuba and potential military action against Iran, dampened appetite for American assets, despite domestic political relief.
SL Green Realty Corp. reported robust fourth-quarter results, highlighting vigorous leasing activity driven in part by AI-related demand and sustained Asian investor interest in New York City assets, while outlining a strategic $2.5 billion asset sale plan.
In a contrarian move, asset manager S.A. Mason has initiated a significant position in the underperforming Akre Focus ETF, signaling a long-term conviction in its concentrated, quality-focused strategy despite recent headwinds.
Lumen Technologies pivots decisively toward the enterprise sector, achieving a pioneering AI management certification while divesting its remaining consumer fiber assets to AT&T, signaling a strategic consolidation around business and government services.
A significant divestment from a short-duration bond ETF highlights a broader portfolio pivot towards growth assets as opportunity costs rise, questioning the role of capital preservation funds in a changing rate environment.
While the energy sector retrenched amid falling crude prices, ExxonMobil executed a massive $20 billion share repurchase program in 2025, underlining its financial muscle and commitment to shareholder returns. The oil giant also reported earnings that beat estimates, driven by record production in the Permian Basin and Guyana, even as it takes a hardline stance on reinvesting in Venezuela.
Analysts at Stifel have raised their price target for Nurix Therapeutics (NRIX) to $35, maintaining a Buy rating ahead of anticipated 2026 clinical milestones for its lead asset, bexobrutinib. The move comes as Wells Fargo also adjusted its target, highlighting divergent near-term views but shared long-term optimism for the biotech firm.
The Walt Disney Company has placed a $30 billion valuation on ESPN as part of its newly finalized strategic partnership with the National Football League, which includes complex future equity options and a major integration of NFL media assets.
Newly released court documents reveal the disgraced financier's last will, signed days before his 2019 death, which directed his fortune—including Little St. James island—to his girlfriend, staff, and accomplices, though most assets remain tied up in victim settlements.
A dual shift in U.S. sanctions and Venezuelan oil law is unlocking the country's vast reserves for American companies, marking a potential turning point after decades of nationalization and economic isolation.
Ovid Therapeutics (NASDAQ: OVID) has garnered analyst optimism following positive Phase 1 trial results for its novel neurological drug candidate and a recent 'Outperform' initiation. The biotech firm is now shifting focus to a more potent oral therapy, with key regulatory milestones ahead.
Driven by falling costs and strong incentives, heavy manufacturing is increasingly turning to on-site solar power. This shift is transforming large factory roofs from passive structures into strategic assets for cutting energy bills and emissions.
The Rafah border crossing between Gaza and Egypt is set to partially reopen Sunday, marking a fragile step in the U.S.-brokered ceasefire. While offering a lifeline for medical evacuees and displaced families, the operation will be tightly controlled by Israeli, Egyptian, and EU officials, with significant restrictions on the movement of people and goods.
Despite a post-transition share price dip, Berkshire Hathaway's unique ecosystem of cash-generating assets, a colossal insurance 'float,' and a discounted valuation suggest the conglomerate is built to last, even without its legendary leader.
KKR & Co.'s shares have retreated over 10% this year, prompting investors to question if the alternative asset manager's long-term growth story justifies its premium valuation. We analyze key metrics and expert narratives to gauge the stock's true appeal.
U.S. stocks advanced cautiously Monday as investors braced for a wave of corporate earnings reports, while crude oil prices tumbled sharply. The focus remains on key tech results and evolving geopolitical developments affecting global trade and energy markets.
Atlanta ranks ninth nationally as a favorable market for homebuyers, driven by increased inventory and moderating prices, according to new Realtor.com data. The trend highlights a broader shift toward buyer leverage across Sun Belt metros.
As NorthWestern Energy Group (NWE) approaches its quarterly report, a surge in share price has investors questioning whether optimism has outpaced fundamentals. With shares trading above analyst targets, the debate centers on future growth prospects versus current valuation concerns.
